Close Menu

HIV

Health management-services and diagnostics firm Alere is developing a pair of nucleic acid testing platforms, representing the company's first major move into the molecular diagnostics space, according to recent company presentations.

Cepheid last week reported a 28 percent spike in first-quarter revenues driven primarily by strong sales in its clinical diagnostics business, including record sequential growth in clinical reagent sales.

Benitec Biopharma said this week that it has non-exclusively licensed its expressed RNAi technology to Calimmune for use in developing an RNAi-based HIV/AIDS treatment.

Siemens Inks New Companion Dx Collaborations with ViiV Healthcare, Tocagen

This story originally ran on Dec. 22.
By Adam Bonislawski

Pages

Following its departure from the European Union, the UK is to implement a fast-track visa program aimed at attracting scientific talent to Britain, according to BBC News.

ScienceInsider reports that researchers in Brazil are concerned that a creationist was chosen to run the agency that oversees graduate study programs there.

The Washington Post reports that researchers are quickly analyzing the coronavirus that has been causing illness and sharing their findings.

In PLOS this week: common variant associated with BMI in Arctic populations, analysis of microRNA markers associated with being born small for gestational age, and more.